Učitavanje...
The β(3)‐adrenoceptor agonist mirabegron increases human atrial force through β(1)‐adrenoceptors: an indirect mechanism?
BACKGROUND AND PURPOSE: Mirabegron has been classified as a β(3)‐adrenoceptor agonist approved for overactive bladder syndrome. We investigated possible cardiac effects of mirabegron in the absence or presence of β‐adrenoceptor subtype antagonists. In view of its phenylethanolamine structure, we inv...
Spremljeno u:
| Izdano u: | Br J Pharmacol |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley and Sons Inc.
2017
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5522995/ https://ncbi.nlm.nih.gov/pubmed/28574581 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.13897 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|